Who is sponsoring NCT06920225?

NCT06920225 is sponsored by Florida State University.

What drugs are being tested in NCT06920225?

Interventions in NCT06920225: Maintain home-based schedule.

What condition does NCT06920225 study?

NCT06920225 studies Transmeridian Travel.

Is NCT06920225 still recruiting?

NCT06920225 is currently completed. Last updated 22 August 2025.

Last reviewed 2025-08-22 · How we verify

NCT06920225

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transmeridian Travel in Elite Female Athletes

Completed NA Last updated 22 August 2025

What this trial tests

NA trial testing Maintain home-based schedule in Transmeridian Travel in 21 participants. Completed in 1 May 2025.

Timeline

15 February 2025

Primary endpoint
1 May 2025

1 May 2025

Quick facts

Lead sponsor	Florida State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	21
Start date	15 February 2025
Primary completion	1 May 2025
Estimated completion	1 May 2025
Sites	1 location across United States

Drugs / interventions tested

Maintain home-based schedule

Conditions studied

Transmeridian Travel — all drugs for Transmeridian Travel →

Sponsor

Florida State University

Who can join

Adults 18 to 28, female only, with Transmeridian Travel. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will investigate whether maintaining a home-based time zone schedule will attenuate any decrements to sleep and performance experienced following transmeridian travel in elite female athletes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Florida State University trials

Trials by the same sponsor.

NCT06127914 — Learning Early Infant Feeding Cues · NA · not yet recruiting
NCT06015581 — Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida · NA · not yet recruiting
NCT07467473 — Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression · NA · enrolling by invitation
NCT07221448 — Sodium vs Potassium Education to Improve Vascular Health · NA · recruiting
NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06920225 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Florida State University
Last refreshed: 22 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06920225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing